Doktorgradsavhandling

• Trond Trætteberg Serkland (2026). Towards model informed precision dosing of anti-CD20 therapeutic monoclonal antibodies in relapsing remitting multiple sclerosis. (ekstern lenke)

Konferanseforedrag

• Trond Trætteberg Serkland; Erik Ingmar Hallin; Kjell-Morten Myhr et al. (2022). Rituximab in the treatment of multiple sclerosis: A pharmacokinetic-pharmacodynamic model. (ekstern lenke)

Konferanseposter

• Erik Ingmar Hallin; Tormod Karlsen Bjånes; Trond Trætteberg Serkland et al. (2024). A high-throughput, low-cost LC-MS/MS panel for precision analysis of therapeutic antibodies. (ekstern lenke)
• Erik Ingmar Hallin; Trond Trætteberg Serkland; KJELL OVE FOSSAN et al. (2024). A rapid, automatable multiplex LC-MS/MS protocol for concomitant analysis of therapeutic antibodies. (ekstern lenke)
• Jon Andsnes Berg; Silje Skrede; Joakim Hansen et al. (2023). "Virtual Pharma" - a digital tool for visualizing pharmacokinetics and pharmacodynamics. (ekstern lenke)
• Trond Trætteberg Serkland; Erik Ingmar Hallin; Kjell-Morten Myhr et al. (2022). LC-MS/MS quantification of ocrelizumab in the treatment of multiple sclerosis. (ekstern lenke)
• Trond Trætteberg Serkland; Erik Ingmar Hallin; KJELL OVE FOSSAN et al. (2021). Establishing an LC-MS/MS method as a tool in a TDM approach when treating multiple sclerosis with monoclonal antibodies. (ekstern lenke)

Leserbrev

• Trond Trætteberg Serkland (2019). T.T. Serkland og medarbeidere svarer :. (ekstern lenke)
• Trond Trætteberg Serkland; Ilah Nygaard; Elena Kvan et al. (2018). Akutt telefonisk varsling om avvikende farmakologiske prøvesvar :. (ekstern lenke)

Masteroppgave

• Lars Herfindal; Martina Stipic; Trond T. Serkland et al. (2020). Drug transport in blood: Lipoproteins as transporters of psychotropic drugs. (ekstern lenke)

Vitenskapelig artikkel

• Trond Trætteberg Serkland; Anna-Kristina Fredheim Oma; Erik Ingmar Hallin et al. (2026). Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis. (ekstern lenke)
• Jon Andsnes Berg; Trond Trætteberg Serkland; Monika Kvernenes et al. (2026). Student Perceptions of a Virtual Reality Animation for Teaching Absorption and Bioavailability in Pharmacology: A Mixed Methods Evaluation. (ekstern lenke)
• Jon Andsnes Berg; Øyvind Repstad; Trond Trætteberg Serkland et al. (2025). Student perspectives on AI‐supported formative assessment in pharmacology. (ekstern lenke)
• Trond Trætteberg Serkland; Silje Skrede; Erik Ingmar Hallin et al. (2025). Pharmacokinetic-pharmacodynamic modelling in a clinical pilot study of rituximab in multiple sclerosis: Towards personalized dosing interval. (ekstern lenke)
• Hilde Marie Torgauten; Therese Bredholt Onyango; Sonja Ljostveit et al. (2024). Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. (ekstern lenke)
• Erik Ingmar Hallin; Trond Trætteberg Serkland; Tormod Karlsen Bjånes et al. (2024). High-throughput, low-cost quantification of 11 therapeutic antibodies using caprylic acid precipitation and LC-MS/MS. (ekstern lenke)
• Jon Andsnes Berg; R. Rajendiran; Trond Trætteberg Serkland et al. (2023). Extended Detection Window for Gamma-Hydroxybutyrate in the Urine of an Elderly Woman. (ekstern lenke)
• Erik Ingmar Hallin; Trond Trætteberg Serkland; Kjell-Morten Myhr et al. (2022). Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. (ekstern lenke)
• Trond Trætteberg Serkland; Gro Helen Dale; Ingeborg Caroline Kaldestad et al. (2021). Oxazepam Detected in Urine 79 Days After Withdrawal of Diazepam: A Case Report. (ekstern lenke)
• Ingrid Anna Teigen; Trond T. Serkland; Thomas Pahr et al. (2019). Bør flere tilbys behandling med cannabinoider?. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.